FDA Inspection 941080 — Acuity Specialty Products, Inc.

Acuity Specialty Products, Inc. — FEI 3006317477

The FDA completed an inspection of Acuity Specialty Products, Inc. on September 11, 2015 in Chambersburg, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 20 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 11, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chambersburg, PA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
113321 CFR 211.25(a)GMP Training Frequency
121521 CFR 211.67(b)Written procedures not established/followed
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
188321 CFR 211.165(a)Testing and release for distribution
201921 CFR 211.188(b)(7)Documentation of Actual Yield and Theoretical Yield
202721 CFR 211.192Investigations of discrepancies, failures
220021 CFR 211.186(b)(4)Variation in the Amount of Components Used
220321 CFR 211.186(b)(7)Theoretical Yield and Percentages
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
361021 CFR 211.160(b)(3)Drug product sample
361321 CFR 211.160(b)(4)Establishment of calibration procedures
363321 CFR 211.170(b)(1)Reserve sample retention time
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
437221 CFR 211.188(b)(8)Labeling control records including specimens or copies
439121 CFR 211.180(e)(2)Items to cover on annual reviews
441321 CFR 211.194(a)(8)Second person sign off